Eagle Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-134,641
Closed -$4.42M 630
2021
Q3
$4.42M Sell
134,641
-45,579
-25% -$1.7M 0.02% 414
2021
Q2
$7.69M Buy
180,220
+2,475
+1% +$96.8K 0.03% 371
2021
Q1
$6.64M Sell
177,745
-13,190
-7% -$561K 0.03% 384
2020
Q4
$8.36M Sell
190,935
-17,856
-9% -$672K 0.05% 316
2020
Q3
$7.7M Sell
208,791
-1,371
-0.7% -$44.3K 0.04% 315
2020
Q2
$6.51M Buy
210,162
+25,514
+14% +$953K 0.04% 338
2020
Q1
$6.5M Buy
184,648
+28,352
+18% +$1.2M 0.04% 330
2019
Q4
$7.59M Buy
156,296
+3,517
+2% +$160K 0.04% 351
2019
Q3
$7.26M Buy
152,779
+2,278
+2% +$107K 0.04% 350
2019
Q2
$6.46M Buy
150,501
+114,381
+317% +$4.44M 0.03% 376
2019
Q1
$1.4M Buy
+36,120
New +$1.22M 0.01% 531

Other funds holding CSII

Eagle Asset Management's CSII Position: Q4 2021 in Review

Eagle Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 134,641 shares — an estimated $4.42M sold.

Eagle Asset Management first reported a position in CSII in Q1 2019 and held it in 11 quarters. The position peaked at $8.36M in Q4 2020. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

  • Eagle Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
  • Eagle Asset Management sold 134,641 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $4.42M.
  • Eagle Asset Management first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 11 quarters.
  • Eagle Asset Management's Cardiovascular Systems, Inc. position peaked at $8.36M in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on Eagle Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.